Mizuho analyst Graig Suvannavejh upgraded Belite Bio (BLTE) to Outperform from Neutral with a $194 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLTE:
- Belite Bio TBA Spot Secondary; price range $150.00-$154.00
- Belite Bio Reports Increased Cash Reserves Amid Rising R&D Costs
- Belite Bio Announces Public Offering of ADSs to Fund Expansion
- Belite Bio announces American Depositary shares offering, no amount given
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!